These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30689936)

  • 1. Hyaluronan histochemistry-a potential new tool to assess the progress of liver disease from simple steatosis to hepatocellular carcinoma.
    Mustonen AM; Salvén A; Kärjä V; Rilla K; Matilainen J; Nieminen P
    Glycobiology; 2019 Apr; 29(4):298-306. PubMed ID: 30689936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma.
    Singhi AD; Jain D; Kakar S; Wu TT; Yeh MM; Torbenson M
    Am J Surg Pathol; 2012 May; 36(5):710-5. PubMed ID: 22498821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT; de Oliveira CP; Corrêa-Giannella ML; Soares IC; Kubrusly MS; Bellodi-Privato M; de Mello ES; de Lima VM; Carrilho FJ; Alves VA
    Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis.
    Yang YM; Noureddin M; Liu C; Ohashi K; Kim SY; Ramnath D; Powell EE; Sweet MJ; Roh YS; Hsin IF; Deng N; Liu Z; Liang J; Mena E; Shouhed D; Schwabe RF; Jiang D; Lu SC; Noble PW; Seki E
    Sci Transl Med; 2019 Jun; 11(496):. PubMed ID: 31189722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma.
    Li Y; Zhang W; Doughtie A; Cui G; Li X; Pandit H; Yang Y; Li S; Martin R
    Oncotarget; 2016 Aug; 7(32):52329-52339. PubMed ID: 27447573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
    Wu J
    Oncotarget; 2016 Jul; 7(27):42762-42776. PubMed ID: 27072576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors.
    Liebig M; Hassanzada A; Kämmerling M; Genz B; Vollmar B; Abshagen K
    Exp Biol Med (Maywood); 2018 Jan; 243(1):1-12. PubMed ID: 29065724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of hyaluronan, HAS1-2, and HYAL1-2 in oral lichen planus.
    Siponen M; Kullaa A; Nieminen P; Salo T; Pasonen-Seppänen S
    J Oral Pathol Med; 2015 Jul; 44(6):401-9. PubMed ID: 25421996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
    Cui G; Martin RC; Jin H; Liu X; Pandit H; Zhao H; Cai L; Zhang P; Li W; Li Y
    J Exp Clin Cancer Res; 2018 Jul; 37(1):136. PubMed ID: 29973237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel up-regulation of FGF-2 and hyaluronan during development of cardiac hypertrophy in rat.
    Hellman U; Hellström M; Mörner S; Engström-Laurent A; Aberg AM; Oliviero P; Samuel JL; Waldenström A
    Cell Tissue Res; 2008 Apr; 332(1):49-56. PubMed ID: 18196276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Chow MD; Lee YH; Guo GL
    Mol Aspects Med; 2017 Aug; 56():34-44. PubMed ID: 28442273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of the Y220C mutant p53 against steatosis: good news?
    Gori M; Barbaro B; Arciello M; Maggio R; Viscomi C; Longo A; Balsano C
    J Cell Physiol; 2014 Sep; 229(9):1182-92. PubMed ID: 24395441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.
    Tiainen S; Oikari S; Tammi M; Rilla K; Hämäläinen K; Tammi R; Kosma VM; Auvinen P
    Breast Cancer Res Treat; 2016 Nov; 160(2):237-247. PubMed ID: 27683279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
    Zoller H; Tilg H
    Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer.
    Paiva P; Van Damme MP; Tellbach M; Jones RL; Jobling T; Salamonsen LA
    Gynecol Oncol; 2005 Aug; 98(2):193-202. PubMed ID: 15936804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of hyaluronan synthase 1 and distribution of hyaluronan during follicular atresia in pig ovaries.
    Miyake Y; Sakurai M; Tanaka S; Tunjung WA; Yokoo M; Matsumoto H; Aso H; Yamaguchi T; Sato E
    Biol Reprod; 2009 Feb; 80(2):249-57. PubMed ID: 18923162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver disease.
    Vansaun MN; Mendonsa AM; Lee Gorden D
    PLoS One; 2013; 8(9):e73054. PubMed ID: 24039859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse.
    Chan AW; Yu S; Yu YH; Tong JH; Wang L; Tin EK; Chong CC; Chan SL; Wong GL; Wong VW; Chan HL; Lai PB; To KF
    Histopathology; 2016 Dec; 69(6):971-984. PubMed ID: 27380543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.